Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

EMI Share Option Plan

7 May 2014 07:00

RNS Number : 4076G
Biome Technologies PLC
07 May 2014
 



 

7 May 2014

Biome Technologies plc

 ("Biome", "the Company" or "the Group")

 

Notification of awards under EMI Share Option Plan

 

 

The Company announces the following dealings by directors in respect of the Company's ordinary shares of 5p each pursuant to the AIM Rules.

 

On 6 May 2014, the Company granted the following share options under the Biome Technologies plc new EMI Share Option Plan (the "2014 EMI"):

 

 

Name of Individual

 

Maximum number of share options

Paul Mines (Director)

124,787

Declan Brown (Director)

70,303

Other Employees

133,575

Total

328,665

 

Up to 50% of the share options may vest on 4 October 2016 and the balance may vest on 4 October 2017 to the extent that performance conditions relating to an increase in the Company's share price are satisfied.

 

The total number of ordinary shares in respect of which the options may be exercised will be determined by reference to the market value of the Group's shares on the two vesting dates. If the Company's share price exceeds 320p on either of the vesting dates, a value pool equal to a percentage of the Company's actual market capitalisation in excess of a market capitalisation based on this 320p price will be created using the following mechanism:

 

· above 320p (up to including 360p) then the value pool percentage will be 10%

· above 360p (up to including 400p) then the value pool percentage will be 12.5%

· above 400p then the value pool percentage will be 15%

 

This value pool will be used to derive the proportion of share options that vest for each 2014 EMI plan participant, subject to the individual maximums described above. The price payable on exercise by the plan's participants will be 165p, being the closing mid-market price on 2 May 2014.

 

By way of example, assuming a closing share price on the day before the first and second vesting dates of 405p, this would have resulted in an increase in the market capitalisation of the Company of £2,000,000 over a market capitalisation based on the 320p share price. Under this scenario and the rules of the 2014 EMI, 88,182 of the total share options would be capable of being exercised by all of the beneficiaries, representing approximately 27 per cent. of the maximum number of share options being issued.

 

All vested share options must be exercised by 5 May 2019 under the rules of the plan. All awards under the 2010 PEP plan have now been cancelled.

 

In addition, on 6 May 2014 the Company granted an award to John Standen, non-executive Chairman, subject to the 2014 EMI performance conditions described above. If these performance conditions are met, John Standen will be paid a cash sum equal to 6.5% of the value pool created on the same basis that value can be made available under the 2014 EMI. John Standen's existing award made at the time of adoption of the 2010 PEP has been cancelled.

 

 

 

 

-Ends-

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Daniel Stewart & Company plc

David Hart / James Thomas (Nominated Adviser)

Mark Treharne (Broker)

www.danielstewart.co.uk

Tel: +44 (0) 20 7776 6550

Allenby Capital

Chris Crawford/Kelly Gardiner

www.allenbycapital.com

Tel: +44 (0) 20 3002 2070

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKSKESKLEFF
Date   Source Headline
21st Mar 20257:00 amRNSCancellation- Biome Technologies PLC
13th Mar 202512:22 pmRNSResult of GM & update on Cancellation
21st Feb 20257:00 amRNSProposed Cancellation & Notice of GM
18th Dec 20247:00 amRNSSecured Funding Facility
4th Dec 20247:00 amRNSTrading Update and Board Change
13th Nov 20247:00 amRNSTrading Update
25th Oct 20247:00 amRNSAppointment of Non-Executive Director
30th Sep 20245:00 pmRNSTotal Voting Rights
30th Sep 202411:08 amRNSContract win for Stanelco RF Division
20th Sep 20247:00 amRNSInterim Results
13th Sep 202410:58 amRNSHolding(s) in Company
12th Sep 202411:43 amRNSHolding(s) in Company
11th Sep 20243:01 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
9th Sep 20244:51 pmRNSHolding(s) in Company
4th Sep 20242:39 pmRNSResult of General Meeting and TVR
30th Aug 20245:00 pmRNSTotal Voting Rights
23rd Aug 20242:42 pmRNSHolding(s) in Company
22nd Aug 202411:00 amRNSHolding(s) in Company
22nd Aug 20247:00 amRNSResult of Retail Offer, Director dealing and TVR
21st Aug 20244:12 pmRNSHolding(s) in Company
21st Aug 20241:41 pmRNSHolding(s) in Company
16th Aug 20247:05 amRNSRetail offer to raise up to £80,000
16th Aug 20247:01 amRNSProposed Fundraise and other matters
16th Aug 20247:00 amRNSTrading update
10th Jul 20247:00 amRNSDirectorate Change
8th Jul 20247:00 amRNSTrading update
12th Jun 20247:00 amRNSGrant of Options
29th May 202410:57 amRNSResult of AGM, Interim CFO and Directorate Change
22nd May 20242:27 pmRNSContract win for Stanelco RF Division
15th May 20247:00 amRNSNotice of AGM and 2023 Annual Report
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.